Title |
Comparison of Treatment Outcomes of New Smear-Positive Pulmonary Tuberculosis Patients by HIV and Antiretroviral Status in a TB/HIV Clinic, Malawi
|
---|---|
Published in |
PLOS ONE, February 2013
|
DOI | 10.1371/journal.pone.0056248 |
Pubmed ID | |
Authors |
Hannock Tweya, Caryl Feldacker, Sam Phiri, Anne Ben-Smith, Lukas Fenner, Andreas Jahn, Mike Kalulu, Ralf Weigel, Chancy Kamba, Rabecca Banda, Matthias Egger, Olivia Keiser |
Abstract |
Smear-positive pulmonary TB is the most infectious form of TB. Previous studies on the effect of HIV and antiretroviral therapy on TB treatment outcomes among these highly infectious patients demonstrated conflicting results, reducing understanding of important issues. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 33% |
United States | 1 | 33% |
Unknown | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 206 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 1% |
Switzerland | 2 | <1% |
Malawi | 1 | <1% |
Kenya | 1 | <1% |
Tanzania, United Republic of | 1 | <1% |
South Africa | 1 | <1% |
Brazil | 1 | <1% |
Peru | 1 | <1% |
India | 1 | <1% |
Other | 0 | 0% |
Unknown | 194 | 94% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 51 | 25% |
Researcher | 29 | 14% |
Student > Ph. D. Student | 21 | 10% |
Other | 16 | 8% |
Student > Bachelor | 16 | 8% |
Other | 37 | 18% |
Unknown | 36 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 83 | 40% |
Nursing and Health Professions | 20 | 10% |
Social Sciences | 14 | 7% |
Agricultural and Biological Sciences | 7 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 3% |
Other | 33 | 16% |
Unknown | 43 | 21% |